Arsenic in drinking water and mortality from vascular disease: An ecologic analysis in 30 counties in the united states

Archives of Environmental Health

Volumn 49, Issue 5, 1994, Pages 418-427

  Engel, Robert R ^a   Smith, Allan H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; DRINKING WATER;

ADULT; AGED; AORTA ANEURYSM; ARGENTINA; ARTERIOSCLEROSIS; ARTICLE; CONGENITAL HEART DISEASE; ECOLOGY; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TAIWAN; UNITED STATES; VASCULAR DISEASE; WATER CONTAMINATION;

ADULT; AGED; ARSENIC; ARSENIC POISONING; CAUSE OF DEATH; ECOLOGY; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; SMOKING; UNITED STATES; VASCULAR DISEASES; WATER POLLUTANTS, CHEMICAL;

EID: 0028004014     PISSN: 00039896     EISSN: None     Source Type: Journal    
DOI: 10.1080/00039896.1994.9954996     Document Type: Article

References (87)

1. International Agency for Research on Cancer. Some metals and metallic compounds. IARC monographs on the evaluation of the carcinogenic risk of chemicals to man. Vol, 23. lyon: World Health Organization, 1980.
2. Bates MN, Smith AH, Hopenhayn-Rich C. Arsenic ingestion and internal cancers: a review. Am J Epidemiol 1992; 1 35:462-76.
3. Smith AH, Hopenhayn-Rich C, Bates MN, et al. Cancer risks from arsenic in drinking water. Environ Health Persp 1992; 97:259-267.
4. Ceyer L. Ueber die chronischen Hautveranderungen beimArse-nicismus und Betrachtungen uberdie Massenerkrangungen in Re-ichenstein in Schlesien (German). Arch Dermatol Syphil Wien 1898;43:221-82.
5. Ch’i’ IC, Blackwell RQ. A controlled retrospective study of Black-foot disease, an endemic peripheral gangrene disease in Taiwan. Am J Epidemiol 1968; 88:7-24.
6. Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 1968; 40:453-63.
7. Tseng WP. Effects and dose-response relationships of skin cancer and Blackfoot disease with arsenic. Environ Health Persp 1977; 19:109-19.
8. Chen CJ, Chuang YC, Lin TM, Wu HY. Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 1985; 45:5895-99.
9. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY. Athero-genicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of Blackfoot disease. Arteriosclerosis 1988; 8:452-60.
10. Wu MM, Kuo TL, Hwang YH, Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 1989; 130:1123-32.
11. Tseng WP. Blackfoot disease in Taiwan: a 30-year follow-up study. Angiology 1989;40:547-58.
12. Zaldivar R. Arsenic contamination of drinking water and foodstuffs causing endemic chronic poisoning. Beitr Path Bd 1974; 151:384-400.
13. Rosenberg HG. Systemic arterial disease and chronic arsenicism in infants. Arch Pathol 1974; 97:360-65.
14. Borgono JM, Vicent P, Venturino H, Infante A. Arsenic: in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of a treatment plant. Environ Health Persp 1977; 19:103-05.
15. Moran S, Maturana G, Rosenberg H, Casanegra P, Dubernet J. Occlusion coronariennes liees a une intoxication arsenicale chron-ique (French). Arch Mai Coeur 1977; 70:1115-20.
16. Koelsch F. Die beruflichen Arsenschaden im Weinbau und in den gewerblichen Betrieben (German). Arch Gewerbepath Gewerbe-hyg 1958; 16:405-38.
17. Hadjioloff C. Die Blutbildveranderungen bei der chronischen Arsenvergiftung der Winzer in der Rheinpfalz (German). Dtsch Med Wschr 1940; 1 7:459-63.
18. Butzengeiger KH. Ueber periphere Zirkulationsstorungen bei chronischer Arsenvergiftung (German). Klin Wchenschr 1940; 22:523-27.
19. Butzengeiger KH. Ueber die chronische Arsenvergiftung. I. Ekg-Veranderungen und andere Erscheinungen am Flerzen und Gefas-ssystem. II. Schleimhautsymptome und Pathogenese (German). Dtsch Arch Klin Med 1948; 194:1-16.
20. Roth F. Ueber die chronische Arsenvergiftung der Moselwinzer unter besonderer Beriicksichtigung des Arsenkrebses (German). Z Krebsforschng 1956; 61:287-319.
21. Grobe JW. Periphere Durchblutungsstorungen und Akrocyanose bei arsengeschadigten Moselwinzern (German). Berufsdermato-sen 1976; 24:78-84.
22. Kesztele V, Seyfried H. Chronische Arsenvergiftungen in den Weinbaugebieten derOstmark (German). Arch Gewerbepatholo-gie und Gewerbehygiene 1942; 11:361-68.
23. Cuzick J, Evans S, Gillman M, Evans DAP. Medicinal arsenic and internal malignancies. Br J Cancer 1982;45:904-11.
24. Cuzick J, Sasieni P, Evans S. Ingested arsenic, keratoses, and bladder cancer. Am J Epidemiol 1992; 136:417-21.
25. Hill AB, Faning EL. Studies in the incidence of cancer in a factory handling inorganic compounds of arsenic. I. Mortality experience in the factory. Br Ind Med 1948; 5:1-15.
26. Lee AM, Fraumeni JF. Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst 1969; 42:1045-52.
27. Lubin JH, Pottern LM, Blot WJ, Tokudome S, Stone BJ, Fraumeni JF. Respiratory cancer among copper smelter workers: recent mortality statistics. J Occup Med 1981; 23:779-84.
28. Welch K, Higgins I, Oh M, Burchfiel C. Arsenic exposure, smoking, and respiratory cancer in copper smelter workers. Arch Environ Health 1982; 37:325-35.
29. Lee-Feldstein A. Arsenic and respiratory cancer in humans: follow-up of copper smelter employees in Montana. I Natl Cancer Inst 1983;70:601-09.
30. Pinto SS, Bennett BM. Effect of arsenic trioxide exposure on mortality. Arch Environ Health 1963; 7:583-91.
31. Pinto SS, Enterline PE, Henderson V, Varner MO. Mortality experience in relation to a measured arsenic trioxide exposure. Environ Health Persp 1977; 19:127-30.
32. Enterline PE, Marsh GM. Cancer among workers exposed to arsenic and other substances in a copper smelter. Am J Epidemiol 1982;116:895-911.
33. Rencher AC, Carter MW, McKee DW. A retrospective epidemiological study of mortality at a large western copper smelter. J Occup Med 1977; 19:754-58.
34. Axelson O, Dahlgren E, Jansson CD, Rehnlund SO. Arsenic exposure and mortality: a case-referent study from a Swedish copper smelter. Br J Ind Med 1978; 35:8-15.
35. Wall S. Survival and mortality pattern among Swedish smelter workers. Int J Epidemiol 1980; 9:73-87.
36. Iaerup L, Pershagen G, Wall S. Cumulative arsenic exposure and lung cancer in smelter workers: a dose-response study. Am J Ind Med 1989; 15:31-41.
37. Tokudome S, Kuratsune M. A cohort study on mortality from cancer and other causes among workers at a meial refinery. Int I Cancer 1976; 17:310-17.
38. Tsuda T, Nagira T, Yamamoto M, Kume Y. An epidemiological study on cancer in certified arsenic poisoning patients in Toroku. Ind Health 1990; 28:53-62.
39. Ott MG, Holder BB, Gordon HL. Respiratory cancer and occupational exposure to arsenicals. Arch Environ Health 1974; 29:250-55.
40. Sobel W, Bond GG, Baldwin CL, Ducommun DJ. An update of respiratory cancer and occupational exposure to arsenicals. Am J Ind Med 1988; 13:263-70.
41. Mabuchi K, Lilienfeld AM, Snell I M. Cancer and occupational exposure to arsenic: a study of pesticide worker. Prev Med 1980; 9:51-77.
42. Kraetzer AF. Raynaud’s disease associated with chronic arsenical retention—report of case cured by sodium thiosulfate. JAMA 1930;94:1035-37.
43. Oppenheim M. Hauterkrankungen durch arsenhaltigen Mauerab-strich (German). Wiener Klin Wschr 1930; 1:475-76.
44. Kren O. Discussion to Oppenheim’s paper (German). Wiener Klin Wschr 1930; 1:476.
45. Cannon AB. Chronic arsenical poisoning—symptoms and sources. NY State J Med 1936; 36:219-41.
46. Strauss F. Tagung der Deutschen Gesellschaft fur Chirurgie (German). Arch klin Chir 1932; 173:92-93.
47. Durck H. Die pathologische Anatomie im Dienste der Unfallbegu-tachtung (German). Munchener Med Wschr 1937; 3:81-87.
48. Knoth W. Arsenbehandlung (German). Arch Klin Exp Dermatol 1966; 227:228-34.
49. Peters HA, Croft WA, Woolson EA, Darcey BA, Olson MA. Seasonal arsenic exposure from burning chromium-copper-arsenate-treated wood. JAMA 1984; 251:2393-96.
50. Yang TH, Blackwell RQ. Nutritional and environmental conditions in the BlacFormosan Science 1961; 15:101-29.
51. Engel RR, Receveur O. Re: Arsenic ingestion and internal cancers: a review (letter). Am J Epidemiol 1993; 138:896-97.
52. National Research Council. Recommended dietary allowances. 10th ed. Washington, DC: National Academy Press, 1989.
53. Yu HS, Sheu HM, Ko SS, et al. Studies on Blackfoot disease and chronic arsenism in southern Taiwan. J Dermatol 1984; 11:361-70.
54. Lagerkvist B, Linderholm H, Nordberg GF. Vasospastic tendency and Raynaud’s phenomenon in smelter workers exposed to arsenic. Environ Res 1986; 39:465-74.
55. Lagerkvist B, Linderholm H, Nordberg GF. Arsenic and Raynaud’s phenomenon—vasospastic tendency and excretion of arsenic in smelter workers before and after the summer vacation. Int Arch Occup Environ Health 1988; 60:361-64.
56. Goldsmith JR, Deane M, Thom J, Gentry G. Evaluation of health implications of elevated arsenic in well water. In: Water research. Great Britain: Pergamon Press, 1972; 6:1133-36.
57. Feinglass EJ. Arsenic intoxication from well water in the United States. N Engl J Med 1973; 288:828-30.
58. Morton W, Starr G, Pohl D, Stoner J, Wagner S, Weswig P. Skin cancer and water arsenic in Lane County, Oregon. Cancer 1976; 37:2523-32.
59. Harrington JM, Middaugh JP, Morse DL, Housworth J. A survey of a population exposed to high concentrations of arsenic in well water in Fairbanks, Alaska. Am J Epidemiol 1978; 108:377-85.
60. Kreiss K, Zack MM, Feldman RG, et al. Neurologic evaluation of a population exposed to arsenic in Alaskan well water. Arch Environ Health 1983;38:116-21.
61. Southwick JW, Western AE, Beck MM, Whitley T, Isaacs R, Petajan J, Hansen CD. An epidemiological study of arsenic in drinking water in Millard County, Utah. In: Lederer WH, Fensterheim RJ, Eds. Arsenic: industrial, biomedical, environmental perspectives proceedings of the arsenic symposium. Gaithersburg, MD: Van Nostrand Reinhold, 1983.
62. Valentine JL, Reisbord LS, Kang HK, Schluchter MD. Arsenic effects on population health histories. In: Mills CF, Bremner I, Chesters JK, Eds. Trace elements in man and animals—TEMA 5: proceedings of the fifth International Symposium on Trace Elements in Man and Animals. Commonwealth Agricultural Bureaux, 1985:289-92.
63. Larson CD. Historical development of the National Primary Drinking Water Regulations. In: Calabrese EJ, Gilbert CE, Pastides H, Eds. Safe Drinking Water Act: amendments, regulations and standards. Chelsea, Ml: Lewis Publishers, 1989: 3-15.
64. Marcus WL, Rispin AS. Threshold carcinogenicity using arsenic as an example. In: Cothern RC, Mehlman MA, Marcus W, Eds. Risk assessment and risk management of industrial and environmental chemicals. Advances in Modern Environmental Toxicology no. 15. Princeton, NJ: Princeton Publishing, 1988.
65. Science (Applications International Corporation). Estimated national occurrence and exposure to arsenic in public drinking water supplies (revised draft), prepared for the U.S. Environmental Protection Agency, Washington, DC (EPA, contract No. 68-01-7166), 1987.
66. Agency for Toxic Substances and Disease Registry. Toxicological profile for arsenic (draft). Atlanta, GA: U.S. Department of Health and Human Services, 1991.
67. Zierler S, Theodore M, Cohen A, Rothman KJ. Chemical quality of maternal drinking water and congenital heart disease. Int J Epidemiol 1988; 17:589-94.
68. Nordstroem S, Beckman, Nordenson I. Occupational and environmental risks in and around a smelter in northern Sweden. VI. Congenital malformations. Hereditas 1979; 90:297-302.
69. McCarthy J, Merrill D, Marcus A, et al. The SEEDIS project: a summary overview of the Social, Economic, Environmental, Demographic Information System. Lawrence Berkeley Laboratory Report, PUB-424 Rev, 1982.
70. Rosenbaum PR, Rubin DB. Difficulties with regression analyses of age-adjusted rates. Biometrics 1984; 40:437-43.
71. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 2: the design and analysis of cohort studies. IARC Scientific Publications No. 82, Lyon, 1987.
72. Gardner MG, Altman DG, eds. Statistics with confidence. Br Med J, 1989.
73. Morgenstern H. Uses of ecologic analysis in epidemiologic research. Am J Pub Health 1982; 72:1336-44.
74. Richardson S, Stuecker I, Hemon D. Comparison of relative risks obtained in ecological and individual studies: some methodological considerations. Int J Epidemiol 1987; 16:111-20.
75. Piantadosi S, Byar DP, Green SB. The ecological fallacy. Am J Epidemiol 1988; 127:893-904.
76. Greenland S, Morgenstern H. Ecological bias, confounding, and effect modification. Int J Epidemiol 1989; 18:269-74.
77. Walter SD. The ecologic method in the study of environmental health. II. Methodologic issues and feasibility. Environ Health Persp 1991;94:67-73.
78. Brenner H, Savitz DA, Joeckel KH, Greenland S. Effects of nondifferential exposure misclassification in ecologic studies. Am J Epidemiol 1992; 135:85-95.
79. Greenland S. Divergent biases in ecologic and individual-level studies. Stat Med 1992; 11:1209-23.
80. Greenland S, Robins J. Ecologic studies: biases, misconceptions, and counterexamples. Am J Epidemiol (in press).
81. Rothman KJ. Modern epidemiology. Boston, MA: Little, Brown and Company, 1986.
82. Higgins MW. Chronic airways disease in the United States: trends and determinants. Chest 1989; 96(suppl):328S-34S.
83. Shopland DR, Niemcryk SJ, Marconi MM. Geographic and gender variations in total tobacco use. Am J Pub Health 1992; 82:103-06.
84. Sackett DL, Winkelstein W Jr. The epidemiology of aortic and peripheral atherosclerosis: a selective review. J Chron Dis 1965; 18:775-95.
85. Israel RA, Rosenberg HM, Curtin LR. Analytical potential for multiple cause-of-death data. Am J Epidemiol 1986; 124:161-79.
86. Moriyama IM, Baum WS, Haenszel WM, Mattison BF. Inquiry into diagnostic evidence supporting medical certifications of death. Am J Pub Health 1958;48:1376-87.
87. Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH. Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev (in press).